Hepatocellular carcinoma (HCC): Causes. Treatments. Overview - Youness, Eman R
33,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Liver cancer, primarily hepatocellular carcinoma (HCC), which often develops in the context of cirrhosis, is the second most lethal cancer worldwide. Its mortality is persistently rising in Europe, North and South America, and Africa, whereas in East Asia, there is a decreasing trend. In 2013, cirrhosis was estimated to cause over 1.2 million deaths (2% of global deaths), marking a 47% increase since 1990. Cirrhosis and HCC are major life-limiting consequences of progressive fibrotic liver diseases, which are mainly caused by hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol abuse, and non-alcoholic fatty liver disease (NAFLD).…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Liver cancer, primarily hepatocellular carcinoma (HCC), which often develops in the context of cirrhosis, is the second most lethal cancer worldwide. Its mortality is persistently rising in Europe, North and South America, and Africa, whereas in East Asia, there is a decreasing trend. In 2013, cirrhosis was estimated to cause over 1.2 million deaths (2% of global deaths), marking a 47% increase since 1990. Cirrhosis and HCC are major life-limiting consequences of progressive fibrotic liver diseases, which are mainly caused by hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol abuse, and non-alcoholic fatty liver disease (NAFLD).
Autorenporträt
Dr. Eman Refaat Youness, MD, is a Professor of Medical Biochemistry at the National Research Centre and Cairo University. The author specializes in experimental design, clinical research, HPLC, oxidative stress, PCR, and medical biochemical analysis, and has extensive international research experience.